CHE - Chemed Corp.
(NaN%)
Buy
Strong Growth and Improving●Stock Price Attractive
68%
based on last 5 year data.
Income Statement is STRONG
Revenue Growth is 7.27%
Operating Income Growth is 51.4%
Net Income Growth is 45.26%
Earnings Per Share (EPS) Growth is 46.36%
Net Margin is 15.36%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 1.1
Debt Ratio is 0.37
Current Debt to Net Income Ratio is 0.0
Total Debt to Total Assets Ratio is 0.0
Cash Flow is STRONG
Cash from Operations Growth is 62.42%
Capital Expenditure is High
Net Increase in Cash is Positive
Long Term Score Trend is POSITIVE
Investment Risk is Low
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Chemed Corp. (CHE) - http://www.chemed.com/
Exchange - NEW YORK STOCK EXCHANGE, INC.
Industry - Home Health Care Services
Sector - Health Care and Social Assistance
CEO - Kevin McNamara
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.
Know the Stock © 2021 and future.